Morales, Leah Mae R.
HRN: 22-95-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2023
CEFOTAXIME 500MG (VIAL)
04/27/2023
05/04/2023
IVTT
2g
Q12
Ectopic Pregnancy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes